RT Journal Article
SR Electronic
T1 Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
JF BMJ Case Reports
JO BMJ Case Reports
FD BMJ Publishing Group Ltd
SP e242220
DO 10.1136/bcr-2021-242220
VO 14
IS 5
A1 Omar Fueyo-Rodriguez
A1 Benjamin Valente-Acosta
A1 Rodolfo Jimenez-Soto
A1 Yvette Neme-Yunes
A1 Sergio Ignacio Inclán-Alarcón
A1 Roxana Trejo-Gonzalez
A1 Miguel Ángel García-Salcido
YR 2021
UL http://casereports.bmj.com/content/14/5/e242220.abstract
AB Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer–BioNTech).